Daniela Constanza Mestre Congregado-rekin lankidetzan egindako argitalpenak (5)

2021

  1. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment

    Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887

2020

  1. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

    Nature Communications, Vol. 11, Núm. 1

2018

  1. Atorvastatin provides a new lipidome improving early regeneration after partial hepatectomy in osteopontin deficient mice

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease

    Journal of Hepatology, Vol. 62, Núm. 3, pp. 673-681

2013

  1. Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis

    Hepatology, Vol. 58, Núm. 4, pp. 1296-1305